Related Experiment Videos
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa
Abstract:
In chronic P. aeruginosa infection, lung tissue damage is induced by either the microorganism or the inflammatory response. We investigated, in an animal model, whether a non-steroidal anti-inflammatory drug, ibuprofen, reduced lung inflammation produced by P. aeruginosa. Lung lavages, pulmonary clearance of P. aeruginosa and lung pathology were studied in CD-1 mice injected with sodium ibuprofenate. A single dose of the drug, injected immediately after 30 min exposure to the P. aeruginosa aerosol, decreased the recruitment of granulocytes into airways in a dose-dependent manner. Pretreatment with 2 doses of the drug 18 and 6 h before the P. aeruginosa challenge was even more effective. The kinetics of changes in prostaglandin E2, 6-keto-prostaglandin F1 alpha and thromboxane B2 concentrations in lung lavage fluids after P. aeruginosa aerosol were also modified by ibuprofen. Moreover, ibuprofen treatment did not impair lung clearance of the challenge microorganisms, and the animals had less inflammation of the lungs.
Insights
Ibuprofen, a non-steroidal anti-inflammatory drug, effectively reduced lung inflammation caused by Pseudomonas aeruginosa infection in mice. This treatment did not hinder the clearance of the bacteria, offering a potential therapeutic strategy.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Chronic Pseudomonas aeruginosa infection leads to lung tissue damage.
- Inflammation is a key factor in P. aeruginosa-induced lung injury.
- Non-steroidal anti-inflammatory drugs (NSAIDs) may mitigate this inflammation.
Purpose of the Study:
- To investigate the efficacy of ibuprofen in reducing P. aeruginosa-induced lung inflammation in an animal model.
- To assess the impact of ibuprofen on bacterial clearance and lung pathology.
Main Methods:
- CD-1 mice were exposed to P. aeruginosa aerosol.
- Sodium ibuprofenate was administered at various time points and doses.
- Lung lavage fluid analysis, bacterial clearance, and lung pathology were evaluated.
Main Results:
- Ibuprofen administration dose-dependently decreased granulocyte recruitment into airways.
- Pretreatment with ibuprofen was more effective than post-exposure treatment.
- Ibuprofen altered prostaglandin and thromboxane levels in lung lavage fluid.
- Lung clearance of P. aeruginosa was not impaired by ibuprofen.
- Animals treated with ibuprofen exhibited reduced lung inflammation.
Conclusions:
- Ibuprofen effectively reduces P. aeruginosa-induced lung inflammation in mice.
- The anti-inflammatory effects of ibuprofen do not compromise bacterial clearance.
- Ibuprofen represents a potential therapeutic agent for managing P. aeruginosa lung infections.